Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.24B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$552M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$535M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$471M |
| 5 |
Palo Alto Networks
PANW
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.11B |
| 2 |
Apple
AAPL
|
+$2.02B |
| 3 |
Microsoft
MSFT
|
+$612M |
| 4 |
Amazon
AMZN
|
+$554M |
| 5 |
iShares MSCI EAFE Value ETF
EFV
|
+$420M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.61% |
| 2 | Consumer Discretionary | 1.65% |
| 3 | Financials | 1.07% |
| 4 | Healthcare | 1.03% |
| 5 | Communication Services | 0.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8001
GeneDx Holdings
WGS
$2.32B
| $64.2K | ﹤0.01% |
17,650
-3,979
| -18% | -$21.8K |
|
8002
PUT
UWM Holdings
UWMC
$478M
| $63.5K | ﹤0.01% |
13,100
-5,100
| -28% | -$29.4K |
|
8003
PUT
Brookdale Senior Living
BKD
$3.27B
| $63.3K | ﹤0.01% |
15,300
-1,800
| -11% | -$7.23K |
|
8004
PUT
RLX Technology
RLX
$2.44B
| $63.3K | ﹤0.01% |
41,900
-4,400
| -10% | -$6.89K |
|
|
MESO
8005
Mesoblast
MESO
$2.16B
| $62.9K | ﹤0.01% |
25,557
-29,079
| -53% | -$139K |
|
8006
Blend Labs
BLND
$357M
| $62.8K | ﹤0.01% |
45,859
-175,654
| -79% | -$213K |
|
8007
BARK
BARK
$96.7M
| $62.8K | ﹤0.01% |
2,617
-381
| -13% | -$10.6K |
|
8008
CALL
Microvast
MVST
$291M
| $62.7K | ﹤0.01% |
+33,200
| New | +$71.1K |
|
8009
PUT
Vroom Inc
VRM
$51.2M
| $62.7K | ﹤0.01% |
+700
| New | +$88.3K |
|
|
AFMD
8010
DELISTED
Affimed
AFMD
| $62K | ﹤0.01% |
12,981
-24,600
| -65% | -$136K |
|
8011
PUT
MannKind Corp
MNKD
$1.26B
| $62K | ﹤0.01% |
15,000
-5,100
| -25% | -$22.9K |
|
|
TGB
8012
Trekor Metals
TGB
$3.21B
| $61.8K | ﹤0.01% |
48,672
+8,586
| +21% | +$11.9K |
|
8013
Solid Power Inc Warrant
SLDPW
$8.05M
| $61.7K | ﹤0.01% |
262,603
+423
| +0.2% | +$147 |
|
8014
IHS Holding
IHS
$2.79B
| $61.6K | ﹤0.01% |
+11,103
| New | +$82.3K |
|
|
PIM
8015
Franklin Master Intermediate Income Trust
PIM
$153M
| $61.4K | ﹤0.01% |
+20,332
| New | +$63.9K |
|
8016
CALL
Hudbay
HBM
$12.4B
| $61.4K | ﹤0.01% |
12,600
-31,500
| -71% | -$160K |
|
|
MVF
8017
DELISTED
BlackRock MuniVest Fund
MVF
| $61.2K | ﹤0.01% |
+10,101
| New | +$66.5K |
|
|
MAPS
8018
DELISTED
WM TECHNOLOGY INC A
MAPS
| $60.6K | ﹤0.01% |
45,909
-103,061
| -69% | -$124K |
|
|
RAD
8019
PUT
DELISTED
Rite Aid Corporation
RAD
| $60.5K | ﹤0.01% |
135,100
+124,200
| +1,139% | +$166K |
|
8020
Banco Bradesco
BBDO
$34.6B
| $60.4K | ﹤0.01% |
23,983
-76,551
| -76% | -$216K |
|
|
IONR
8021
Ioneer
IONR
$268M
| $60.2K | ﹤0.01% |
+10,164
| New | +$74.5K |
|
|
EVLVW
8022
DELISTED
Evolv Technologies Warrant
EVLVW
| $60K | ﹤0.01% |
75,000
-286
| -0.4% | -$403 |
|
8023
CALL
Caribou Biosciences
CRBU
$165M
| $59.8K | ﹤0.01% |
+12,500
| New | +$77.5K |
|
8024
CALL
BioXcel Therapeutics
BTAI
$28.7M
| $59.5K | ﹤0.01% |
1,469
-3,581
| -71% | -$362K |
|
8025
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$637M
| $59.2K | ﹤0.01% |
777
-352
| -31% | -$36.1K |
|
Similar funds
Jane Street's Q3 2023 Portfolio in Review
As of Q3 2023, Jane Street held 9,820 positions worth $309B, up 4.1% from $297B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jane Street deployed $28.2B of net new capital in Q3 2023, opening 1,242 new positions and adding to 3,523 existing holdings. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 11,152,855 shares worth $531M.
By sector, the portfolio is most concentrated in Technology at 2.6% of assets, down from 4% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Tesla, an estimated $2.11B trimmed.
- Jane Street's largest Q3 2023 buy was iShares Core MSCI Emerging Markets ETF: 11,152,855 shares worth $531M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $6.24B increase.
- Jane Street's biggest Q3 2023 reduction was Tesla, cutting an estimated $2.11B.
- Jane Street fully exited iShares Silver Trust in Q3 2023, selling an estimated $130M.
- Jane Street's ten largest holdings make up 40% of its $309B portfolio in Q3 2023.
- Jane Street opened 1,242 new positions and closed 1,288 in Q3 2023.
- Jane Street's portfolio value rose 4.1% quarter-over-quarter to $309B.
Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.